Quantum-Si to Present Research and Development Updates at the VIB Next-Generation Protein Analysis and Detection Conference
May 17, 2022--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a life sciences company commercializing single molecule protein sequencing, today announced that it will be participating in the Next-Generation Protein Analysis and Detection Conference, a VIB Tools & Technologies conference, taking place in Ghent, Belgium on May 30-31, 2022.
Brian Reed, Ph.D., Head of Research, will provide an update on the Company's research and development progress in an oral presentation titled, "Real-time dynamic single-molecule protein sequencing on the Quantum-Si platform," on Tuesday, May 31, 2022 at 2:40 ? 3:05 PM CEST. The presentation abstract is available until August 30, 2022 for registered attendees of the event.
About Quantum-Si Incorporated
Quantum-Si is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single molecule next-generation protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at www.quantum-si.com.
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company") today reported its 2023 consolidated annual financial results, as of December 31, 2023, and provided financial information (unaudited)...
At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided:
Resolution in accordance with the Board's proposed dividend of SEK 1.00 per share for the financial year 2023. 29 April, 2024 was adopted as the...
TimelyCare, higher education's most trusted virtual health and well-being provider, has earned recognition as one of the World's Best Digital Health Companies by Newsweek, and has been awarded five Top Workplaces Awards for culture excellence....
Avanos Medical, Inc. will webcast its conference call discussing financial results and business highlights for the first quarter 2024 on Thursday, May 2 at 9 a.m., ET. The company will issue a news release detailing its results before the market...
Beijing Avistone Biotechnology Co., Ltd. (also referred to as Avistone Biotechnology or Avistone), an innovative biotechnology company focused on precision oncology therapeutics, announced the approval to expand the use of vebreltinib (also referred...
Through its 2030 Strategic Plan, NJII plans to double the size of the organization and to exceed $70M revenue as it rolls out various new initiatives focused on accelerating technology translation, spurring innovation and upskilling workers. As...
